Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

被引：0
|
作者：
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构：
[1] Novartis Institutes for BioMedical Research,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Pvt. Ltd,undefined
来源：
European Journal of Clinical Pharmacology | 2015年 / 71卷
关键词：
Pharmacokinetics; Drug-drug interaction; Pradigastat; Acetaminophen; Gastric motility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 432
页数：7
相关论文
共 50 条
  • [41] Mechanisms of pharmacokinetic drug-drug interactions
    Leveque, D.
    Lemachatti, J.
    Nivoix, Y.
    Coliat, P.
    Santucci, R.
    Ubeaud-Sequier, G.
    Beretz, L.
    Vinzio, S.
    REVUE DE MEDECINE INTERNE, 2010, 31 (02): : 170 - 179
  • [42] A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
    Morrison, Gilmour
    Crockett, Julie
    Blakey, Graham
    Sommerville, Kenneth
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (08): : 1009 - 1031
  • [43] Prolonged Drug-Drug Interaction between Terbinafine and Perphenazine
    Park, Young-Min
    PSYCHIATRY INVESTIGATION, 2012, 9 (04) : 422 - 424
  • [44] Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice
    Karbownik, Agnieszka
    Szalek, Edyta
    Sobanska, Katarzyna
    Grabowski, Tomasz
    Wolc, Anna
    Grzeskowiak, Edmund
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 102 : 55 - 62
  • [45] Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
    Anand Joshi
    Jianxia Guo
    Julianne L. Holleran
    Brian Kiesel
    Sarah Taylor
    Susan Christner
    Robert A. Parise
    Brian M. Miller
    S. Percy Ivy
    Edward Chu
    Raman Venkataramanan
    Jan H. Beumer
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 535 - 545
  • [46] Differential pharmacokinetic drug-drug interaction potential of eletriptan between oral and subcutaneous routes
    Patel, Harilal
    Desai, Nirmal
    Patel, Prakash
    Modi, Nirav
    Soni, Krunal
    Dobaria, Nitin
    Srinivas, Nuggehally R.
    XENOBIOTICA, 2019, 49 (10) : 1202 - 1208
  • [47] Drug-Drug Interaction between Oral Zamicastat and Continuous Epoprostenol Infusion at Steady-State Conditions in Healthy Subjects
    Fonseca, Marlene
    Guimaraes, Andreia
    Gama, Helena
    Magalhaes, Luis
    Henriques, Sara Carolina
    Silva, Nuno
    Almeida, Luis
    Soares-da-Silva, Patricio
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (11) : 1361 - 1372
  • [48] Assessment of Drug-drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic Model
    Sakai, Shuhei
    Kobuchi, Shinji
    Ito, Yukako
    Sakaeda, Toshiyuki
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 111 (05) : 1522 - 1530
  • [49] Drug-Drug Interaction between Propofol and Diabetes Treatment Drug Glimepiride
    Mou, Xiao-Li
    Cao, Xiang-Rong
    Wang, Bo
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (07): : 1673 - 1677
  • [50] Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
    Joshi, Anand
    Guo, Jianxia
    Holleran, Julianne L.
    Kiesel, Brian
    Taylor, Sarah
    Christner, Susan
    Parise, Robert A.
    Miller, Brian M.
    Ivy, S. Percy
    Chu, Edward
    Venkataramanan, Raman
    Beumer, Jan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 535 - 545
12345